40
Participants
Start Date
May 31, 2007
Primary Completion Date
February 28, 2011
Study Completion Date
February 28, 2011
Botulinum Toxin Type A injection (BOTOX)
Each subject will receive an injection under EMG guidance into the anterior and middle scalene muscles of either 75 units of BTX-A (experimental group), or normal saline (control group). Both groups will be provided with a stretching and strengthening exercise program.
Botulinum Toxin Type A injection (BOTOX)
Each subject will receive an injection under EMG guidance into the anterior and middle scalene muscles of either 75 units of BTX-A (experimental group), or normal saline (control group). Both groups will be provided with a stretching and strengthening exercise program.
GF Strong Rehabilitation Centre, Vancouver
Collaborators (1)
University of British Columbia
OTHER
Allergan
INDUSTRY